NCT00524407View on ClinicalTrials.gov

Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

273

Participants

Timeline

Start Date

July 31, 1996

Study Completion Date

November 30, 2002

Conditions
ChemotherapyAnemiaCancer
Interventions
DRUG

Epoetin alfa

Sponsors
All Listed Sponsors
lead

Ortho Biotech, Inc.

INDUSTRY

NCT00524407 - Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy | Biotech Hunter | Biotech Hunter